These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9242207)

  • 1. Atrial natriuretic hormone responses to clonidine in patients with panic disorder and in healthy control subjects.
    Kellner M; Wiedemann K
    Eur J Endocrinol; 1997 Jul; 137(1):84-5. PubMed ID: 9242207
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic.
    Kellner M; Herzog L; Yassouridis A; Holsboer F; Wiedemann K
    Am J Psychiatry; 1995 Sep; 152(9):1365-7. PubMed ID: 7653695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide.
    Mukaddam-Daher S; Lambert C; Gutkowska J
    Hypertension; 1997 Jul; 30(1 Pt 1):83-7. PubMed ID: 9231825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonidine in respiratory panic disorder subtype.
    Valença AM; Nardi AE; Mezzasalma MA; Nascimento I; Lopes FL; Zin WA; Versiani M
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):396-8. PubMed ID: 15273833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
    Tancer ME; Stein MB; Black B; Uhde TW
    Am J Psychiatry; 1993 Feb; 150(2):336-7. PubMed ID: 8422091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M; Yassouridis A; Jahn H; Wiedemann K
    Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder.
    Yeragani VK; Tancer M; Uhde T
    Psychiatry Res; 2003 Dec; 121(2):185-96. PubMed ID: 14656453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of noradrenergic and HPA axis functioning in PTSD vs. panic disorder.
    Marshall RD; Blanco C; Printz D; Liebowitz MR; Klein DF; Coplan J
    Psychiatry Res; 2002 Jul; 110(3):219-30. PubMed ID: 12127472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor.
    Gutkowska J; Mukaddam-Daher S; Tremblay J
    J Pharmacol Exp Ther; 1997 May; 281(2):670-6. PubMed ID: 9152372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD; Papp LA; Martinez J; Pine D; Rosenblum LA; Cooper T; Liebowitz MR; Gorman JM
    Am J Psychiatry; 1995 Apr; 152(4):619-22. PubMed ID: 7694915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM
    Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus.
    Peng N; Chambless BD; Oparil S; Wyss JM
    Hypertension; 2003 Mar; 41(3):571-5. PubMed ID: 12623961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
    Tancer ME; Stein MB; Uhde TW
    Biol Psychiatry; 1993 Nov; 34(9):591-5. PubMed ID: 8292687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.